“The special attraction of this modality of treatment is that, unlike vaccines or newly developed drugs, it could, in principle, be made available...
How COVID-19 patients can receive convalescent plasma, who is eligible to donate, and early results of treatment.
Movers in Medicine
AABB announces a new president, president-elect, vice president, and secretary.
Experts discussed recommendations for alpha and beta thalassemia as well as non–transfusion dependent thalassemia.
From the Journals
The TRACT trial showed no significant differences in 28-day mortality or other clinical outcomes by transfusion timing or volume.
An initiative that reduced red blood cell (RBC) transfusions and increased moderate anemia in hospital did not adversely impact patients long-term...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for lusutrombopag to treat severe...
BOSTON—Results of a pilot program suggest preoperative management of anemia can reduce transfusion rates and cut costs, but the effect on patient...
BOSTON—A blood management program for patients undergoing hematopoietic stem cell transplant (HSCT) can reduce inappropriate transfusions and...